Hradyk Т.; Tsysnetska А. The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients with Type 2 Diabetes Mellitus. Actual Problems of Medicine and Pharmacy, [S. l.], v. 3, n. 1, p. 1–10, 2022. DOI: 10.52914/apmp.v3i1.42. Disponível em: https://apmplmi.com/index.php/apmp/article/view/42. Acesso em: 24 apr. 2024.